top of page

BARDA grants Sanofi $43.2 million for Zika vaccine development

The Biomedical Advanced Research and Development Authority (BARDA) in the US Department of Health and Human Services have agreed to fund Sanofi’s manufacture of an inactivated Zika vaccine for phase II development.

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page